Efficacy and safety of etanercept in the treatment of scleroderma-associated joint disease

J Rheumatol. 2007 Jul;34(7):1636-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antirheumatic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Etanercept
  • Female
  • Health Status
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Retrospective Studies
  • Scleroderma, Diffuse / complications
  • Scleroderma, Diffuse / drug therapy*
  • Scleroderma, Diffuse / physiopathology
  • Scleroderma, Limited / complications
  • Scleroderma, Limited / drug therapy*
  • Scleroderma, Limited / physiopathology
  • Severity of Illness Index
  • Synovitis / complications
  • Synovitis / drug therapy*
  • Synovitis / physiopathology

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept